Alamar Biosciences, Inc. (California) (ALMR)
32.74
-1.50
(-4.38%)
USD |
NASDAQ |
Aug 24, 16:00
32.74
0.00 (0.00%)
After-Hours: 20:00
Alamar Biosciences Market Cap : 2.272B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.376B |
| August 20, 2026 | 2.404B |
| August 19, 2026 | 2.466B |
| August 18, 2026 | 2.287B |
| August 17, 2026 | 2.229B |
| August 14, 2026 | 2.301B |
| August 13, 2026 | 2.284B |
| August 12, 2026 | 2.298B |
| August 11, 2026 | 2.538B |
| August 10, 2026 | 1.942B |
| August 07, 2026 | 1.973B |
| August 06, 2026 | 1.948B |
| August 05, 2026 | 1.965B |
| August 04, 2026 | 1.879B |
| August 03, 2026 | 1.876B |
| July 31, 2026 | 1.758B |
| July 30, 2026 | 1.738B |
| July 29, 2026 | 1.689B |
| July 28, 2026 | 1.713B |
| July 27, 2026 | 1.691B |
| July 24, 2026 | 1.794B |
| July 23, 2026 | 1.794B |
| July 22, 2026 | 1.741B |
| July 21, 2026 | 1.743B |
| July 20, 2026 | 1.658B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.799B |
| July 16, 2026 | 1.729B |
| July 15, 2026 | 1.811B |
| July 14, 2026 | 1.875B |
| July 13, 2026 | 1.899B |
| July 10, 2026 | 1.970B |
| July 09, 2026 | 1.835B |
| July 08, 2026 | 1.754B |
| July 07, 2026 | 1.749B |
| July 06, 2026 | 1.779B |
| July 02, 2026 | 1.798B |
| July 01, 2026 | 1.811B |
| June 30, 2026 | 1.878B |
| June 29, 2026 | 1.925B |
| June 26, 2026 | 1.849B |
| June 25, 2026 | 1.862B |
| June 24, 2026 | 1.652B |
| June 23, 2026 | 1.590B |
| June 22, 2026 | 1.579B |
| June 18, 2026 | 1.522B |
| June 17, 2026 | 1.400B |
| June 16, 2026 | 1.390B |
| June 15, 2026 | 1.434B |
| June 12, 2026 | 1.525B |
| June 11, 2026 | 1.538B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| 10X Genomics, Inc. | 8.311B |
| Personalis, Inc. | 1.817B |
| Twist Bioscience Corp. | 8.821B |
| Adaptive Biotechnologies Corp. | 4.062B |
| Champions Oncology, Inc. | 69.30M |
Market Cap Related Metrics
| PS Ratio | 26.79 |
| Price to Book Value | 7.261 |
| Price | 32.74 |
| Earnings Yield | -2.17% |